Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|June 29, 2023
Advances in immunotherapy for gynecological malignanciesMengyan Tu, Junfen XuJournal of Zhejiang University. Science. B|August 19, 2024
Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcomaJunfen Xu, Mengyan TuMedcomm|March 9, 2026
Clinical Application of Peripheral Blood Biomarkers for Solid TumorsXinru Tu, Mengyan Tu, Junfen XuFrontiers in Public Health|May 16, 2025
Satisfaction evaluation of interns with Da Vinci robot surgical demonstration training in gynecologic oncology operationsJunfen Xu, Yumei Zhou, Mengyan TuClinical and Translational Medicine|November 23, 2025
Single-cell landscape of the tumour immune microenvironment in human gynaecologic malignanciesSimin Yin, Sen Li, Mengyan Tu, et al.Cancer Science|July 22, 2024
CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growthYongjie Huang, Xinyi Wei, Mengyan Tu, et al.World Journal of Surgical Oncology|January 4, 2025
Clinicopathological and prognostic factor analyses of primary fallopian tube carcinoma and high-grade serous ovarian cancer: a single-institution retrospective studyMengyan Tu, Xueyan Gao, Tianchen Guo, et al.Journal of Gynecologic Oncology|June 20, 2025
A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of cervical squamous cell carcinoma and adenocarcinomaYixuan Cen, Mengyan Tu, Yanan Zhang, et al.Biomaterials|June 18, 2026
A biocompatible copper based therapeutic nanoplatform for CD44 specific tumor targeted therapy and potent immune reprogrammingYifeng Fang, Mengyan Tu, Xinru Tu, et al.Journal of Nanobiotechnology|February 1, 2025
Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancerSangsang Tang, Yangyang Li, Yifeng Fang, et al.Pageof 2